Evidence map›Paper›PMID 40227602›Full record

ArticleCancers2025

Indisulam Shows an Anti-Cancer Effect on HPV+ and HPV- Head and Neck Cancer.

Tara M Hosseini, Sophie S Jang, Joseph Bendik, Theresa Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tara M HosseiniMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Sophie S JangMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Joseph BendikMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-0877-5639
Theresa GuoMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-1689-3275

Funding

UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
Identification of splice variant derived neo-antigens in head and neck squamous cell carcinoma as targets for tumor vaccine therapyK08CA276999 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Theresa Guo · 2024 to 2026
$706k
NCATS NIH HHS KL2 TR001444NCI NIH HHS 1K08CA276999-01A1NCI NIH HHS K08 CA276999University of California San Diego Altman Clinical and Translational Research Institute 1KL2TR001444
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

head and neck squamous cell carcinomaHNSCCHPVHPV-negativeHPV-positiveindisulaminterferon-alphainterferon-gammaRBM39SCC

Identifiers

PMID40227602
PMCPMC11987906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.